E Somm, E Henrichot, A Pernin, CE Juge- … - Diabetes, 2005 - Am Diabetes Assoc Interleukin (IL)-1 is a regulator of inflammation but is also implicated in the
control of energy homeostasis. Because the soluble IL-1 receptor antagonist
(IL-1Ra) is markedly increased in the serum of obese patients and is ... Cited by 30 - Related articles - BL Direct - All 5 versions
E Somm, E Henrichot, A Pernin, CE Juge- … - DIABETES, 2005 - Am Diabetes Assoc Interleukin (IL)-1 is a regulator of inflammation but is also implicated in the
control of energy homeostasis. Because the soluble IL-1 receptor antagonist
(IL-1Ra) is markedly increased in the serum of obese patients and is ... Related articles
E Somm, E Henrichot, A Pernin, CE Juge- … - 糖尿病学杂志, 2005 - journal.shouxi.net Interleukin (IL)-1 is a regulator of inflammation but is also implicated in the
control of energy homeostasis. Because the soluble IL-1 receptor antagonist
(IL-1Ra) is markedly increased in the serum of obese patients and is ... Related articles - Cached
E Somm, P Cettour-Rose, C Asensio, A … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 387–393 DOI 10.1007/s00125-005-0046-x ARTICLE E.
Somm . P. Cettour-Rose . C. Asensio . A. Charollais . M. Klein . ... Cited by 43 - Related articles - BL Direct - All 4 versions
- ►rupress.org T Matsuki, R Horai, K Sudo, Y Iwakura - Journal of Experimental Medicine, 2003 - jem.rupress.org IL-1 is a proinflammatory cytokine that plays important roles in inflammation.
However, the role of this cytokine under physiological conditions is not known
completely. In this paper, we analyzed the role of IL-1 in maintaining body ... Cited by 80 - Related articles - BL Direct - All 6 versions
D Chida, T Osaka, O Hashimoto, Y Iwakura - Diabetes, 2006 - Am Diabetes Assoc Proinflammatory cytokines including interleukin (IL)-1 and IL-6 exert
pleiotropic effects on the neuro-immuno-endocrine system. Previously, we showed
that IL-1 receptor antagonist–deficient (IL-1Ra −/− ) mice show a ... Cited by 25 - Related articles - BL Direct - All 5 versions
- ►shouxi.net MC García, I Wernstedt, A Berndtsson, M Enge … - Diabetes, 2006 - Am Diabetes Assoc Interleukin-1 (IL-1) is a major mediator of inflammation that exerts its
biological activities through the IL-1 type I receptor (IL-1RI). The body
weights of IL-1RI −/− mice of both sexes started to deviate from those ... Cited by 36 - Related articles - BL Direct - All 7 versions
- ►endojournals.org CA Meier, E Bobbioni, C Gabay, F … - Journal of Clinical Endocrinology & Metabolism, 2002 - Endocrine Soc To this end, we measured serum IL-1Ra levels in 20 morbidly obese nondiabetic
subjects [body mass index (BMI), 45 ± 6 kg/m 2 ; serum leptin, 52 ± 20 ng/ml]
as well as in 10 age- and sex-matched lean controls (BMI, 22 ± 2 kg/m 2 ; ... Cited by 105 - Related articles - BL Direct - All 4 versions
- ►endojournals.org L Strandberg, M Lorentzon, A Hellqvist, S … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: There is growing evidence for interactions between the regulation of
body fat and the immune system. Studies of knockout mice indicate that IL-1 has
an antiobesity effect. ... Objective: The objective of the study was to ... Cited by 12 - Related articles - BL Direct - All 9 versions
CE Juge-Aubry, E Somm, V Giusti, A Pernin, … - Diabetes, 2003 - Am Diabetes Assoc The secreted form of the interleukin-1 receptor antagonist (IL-1Ra) is an
acute-phase protein intervening in the counterregulation of inflammatory
processes. We previously showed that this cytokine antagonist is ... Cited by 94 - Related articles - BL Direct - All 4 versions
